Erlichman N, Baram T, Meshel T, Morein D, Da’adoosh B, Ben-Baruch A. Tumor cell-autonomous pro-metastatic activities of PD-L1 in human breast cancer are mediated by PD-L1-S283 and chemokine axes. Cancers. 2022;14:1042.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Molnár IA, Molnár BÁ, Vízkeleti L, Fekete K, Tamás J, Deák P, et al. Breast carcinoma subtypes show different patterns of metastatic behavior. Virchows Arch. 2017;470:275–83.

Article  PubMed  Google Scholar 

Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, Tan PH. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol. 2010;23:123–33.

Article  CAS  PubMed  Google Scholar 

Eroles P, Bosch A, Pérez-Fidalgo JA, Lluch A. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev. 2012;38:698–707.

Article  CAS  PubMed  Google Scholar 

Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobayashi SV, et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol. 2005;25:9543–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677–704.

Article  CAS  PubMed  Google Scholar 

Freeman GJ, Wherry EJ, Ahmed R, Sharpe AH. Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade. J Exp Med. 2006;203:2223–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7–1 costimulatory molecule to inhibit T cell responses. Immunity. 2007;27:111–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petroff MG, Chen L, Phillips TA, Azzola D, Sedlmayr P, Hunt JS. B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol Reprod. 2003;68:1496–504.

Article  CAS  PubMed  Google Scholar 

Seliger B, Quandt D. The expression, function, and clinical relevance of B7 family members in cancer. Cancer Immunol Immunother. 2012;61:1327–41.

Article  CAS  PubMed  Google Scholar 

Dai C, Lin F, Geng R, Ge X, Tang W, Chang J, et al. Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer. Oncotarget. 2016;7:10332.

Article  PubMed  PubMed Central  Google Scholar 

Dahan R, Sega E, Engelhardt J, Selby M, Korman AJ, Ravetch JV. FcγRs modulate the anti-tumor activity of antibodies targeting the PD-1/PD-L1 axis. Cancer Cell. 2015;28:285–95.

Article  CAS  PubMed  Google Scholar 

Fei Z, Deng Z, Zhou L, Li K, Xia X, Xie R. PD-L1 induces epithelial–mesenchymal transition in nasopharyngeal carcinoma cells through activation of the PI3K/AKT pathway. Oncol Res. 2019;27:801.

Article  PubMed  PubMed Central  Google Scholar 

Mohan N, Hosain S, Zhao J, Shen Y, Luo X, Jiang J, et al. Atezolizumab potentiates Tcell-mediated cytotoxicity and coordinates with FAK to suppress cell invasion and motility in PD-L1+ triple negative breast cancer cells. Oncoimmunology. 2019. https://doi.org/10.1080/2162402X.2019.1624128.

Article  PubMed  PubMed Central  Google Scholar 

Antony GR, Augustine P, Parambil ST, Littleflower AB, Kattoor J, Krishna K, et al. Immunohistochemical expression of PD-L1 and MDR1 in breast tumors: association with clinico-pathological parameters and treatment outcome. Clin Exp Med. 2022. https://doi.org/10.1007/s10238-022-00852-x.

Article  PubMed  Google Scholar 

Liu H, Tekle C, Chen Y-W, Kristian A, Zhao Y, Zhou M, et al. B7–H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Role of B7–H3 in paclitaxel resistance. Mol Cancer Ther. 2011;10:960–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Chen L, Xiong Y, Zheng X, Xie Q, Zhou Q, et al. Knockdown of PD-L1 in human gastric cancer cells inhibits tumor progression and improves the cytotoxic sensitivity to CIK therapy. Cell Physiol Biochem. 2017;41:907–20.

Article  CAS  PubMed  Google Scholar 

Shi S-J, Wang L-J, Wang G-D, Guo Z-Y, Wei M, Meng Y-L, et al. B7–H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCT116 colorectal cancer cells. PLoS ONE. 2013;8:e76012.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lou Y, Diao L, Cuentas ERP, Denning WL, Chen L, Fan YH, et al. Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinomaEMT and inflammatory tumor microenvironment in lung cancer. Clin Cancer Res. 2016;22:3630–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alsuliman A, Colak D, Al-Harazi O, Fitwi H, Tulbah A, Al-Tweigeri T, et al. Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells. Mol Cancer. 2015;14:1–13.

Article  CAS  Google Scholar 

Cao Y, Zhang L, Kamimura Y, Ritprajak P, Hashiguchi M, Hirose S, et al. B7–H1 overexpression regulates epithelial–mesenchymal transition and accelerates carcinogenesis in skin. Cancer Res. 2011;71:1235–43.

Article  CAS  PubMed  Google Scholar 

Chen L, Xiong Y, Li J, Zheng X, Zhou Q, Turner A, et al. PD-L1 expression promotes epithelial to mesenchymal transition in human esophageal cancer. Cell Physiol Biochem. 2017;42:2267–80.

Article  CAS  PubMed  Google Scholar 

Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119:1438–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao C, Su L, Shan J, Zhu C, Liu L, Liu C, et al. IGF/STAT3/NANOG/Slug signaling axis simultaneously controls epithelial-mesenchymal transition and stemness maintenance in colorectal cancer. Stem Cells. 2016;34:820–31.

Article  PubMed  Google Scholar